Omnicell Inc. (NASDAQ:OMCL) shares shot up 1.9% during trading on Thursday . The stock traded as high as $38.34 and last traded at $38.30, with a volume of 74,063 shares. The stock had previously closed at $37.58.

Several research firms recently commented on OMCL. Zacks Investment Research downgraded shares of Omnicell from a “hold” rating to a “sell” rating in a research note on Wednesday, May 4th. FBR & Co increased their target price on shares of Omnicell from $40.00 to $41.00 and gave the stock an “outperform” rating in a report on Friday, July 29th. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $36.71.

The stock has a market cap of $1.38 billion and a price-to-earnings ratio of 97.21. The firm’s 50 day moving average price is $37.07 and its 200-day moving average price is $32.05.

Omnicell (NASDAQ:OMCL) last announced its quarterly earnings results on Thursday, July 28th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.06. The firm had revenue of $175.60 million for the quarter, compared to analyst estimates of $170.89 million. The company’s revenue was up 55.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.28 EPS. On average, equities analysts predict that Omnicell Inc. will post $1.58 earnings per share for the current fiscal year.

In related news, VP Jorge R. Taborga sold 25,979 shares of the business’s stock in a transaction dated Monday, June 6th. The shares were sold at an average price of $33.00, for a total value of $857,307.00. Following the sale, the vice president now directly owns 50,734 shares in the company, valued at approximately $1,674,222. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Jorge R. Taborga sold 1,778 shares of the business’s stock in a transaction dated Friday, August 19th. The shares were sold at an average price of $36.92, for a total transaction of $65,643.76. Following the completion of the sale, the vice president now owns 49,073 shares in the company, valued at $1,811,775.16. The disclosure for this sale can be found here.

A hedge fund recently raised its stake in Omnicell stock. Dimensional Fund Advisors LP increased its stake in shares of Omnicell Inc. (NASDAQ:OMCL) by 3.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,641,466 shares of the company’s stock after buying an additional 51,729 shares during the period. Dimensional Fund Advisors LP owned about 4.63% of Omnicell worth $51,017,000 at the end of the most recent quarter.

Omnicell, Inc (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company operates through two operating segments: Automation and Analytics, and Medication Adherence.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.